---
title: Small Molecule CDMOs in Canada
path: /modalities/small-molecule/canada
companies_count: 13
---

# Small Molecule CDMOs in Canada

13 published CDMOs match Small Molecule in Canada.

Locations in this set include Canada, United States, Bangladesh, France, India, and Italy.

Capabilities that show up most often in this set: Process Development, Quality Control Testing, Formulation Development, CMC Analytical Development, and Small Molecule Development & Manufacturing.

## Matching companies

- [ARSI Canada Inc](/companies/arsicanada)
  - ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh.
- [Altasciences](/companies/altasciences)
  - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
- [Applied Pharmaceutical Innovation](/companies/appliedpharma)
  - Edmonton-based not-for-profit offering integrated CDMO services in sterile fill-finish, oral solid dosage, topical application, and highly potent controlled substance manufacturing. Also provides CRO research, regulatory and quality, and clinical and quantitative support.
- [BioVectra](/companies/biovectra)
  - North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.
- [Burrard Pharmaceuticals](/companies/burrardpharma)
  - Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005.
- [Clearsynth](/companies/clearsynth)
  - Clearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing.
- [Dalton Pharma Services](/companies/dalton)
  - Health Canada–approved and FDA-inspected cGMP contract manufacturer offering integrated drug discovery, development, and manufacturing services including custom synthesis, API production, formulation development, and sterile fill-finish for vials, syringes, and cartridges.
- [Delpharm](/companies/delpharm)
  - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.
- [HAARES ChemTech Inc.](/companies/haareschemtech)
  - HAARES ChemTech provides custom synthesis and contract R&D for complex organic molecules from Edmonton, Canada. Its PhD-level chemists work from milligram to multi-kilogram scale, and the company also offers process development and intermediate manufacture.
- [Halo Pharma](/companies/halo-pharma)
  - Halo Pharma provides end-to-end pharmaceutical development and manufacturing for small molecule therapeutics across solids, semi-solids, oral liquids, and sterile injectables, with two North American cGMP facilities and an accelerated 16–20 week tech transfer program.
- [Medicap Laboratories](/companies/medicaplab)
  - Canadian CDMO for advanced oral drug delivery, offering contract manufacturing, pharmaceutical packaging, analytical testing and product development. Proprietary Hypermatrix, PODRAS and nPODDDS platforms target controlled-release and abuse-deterrent products.
- [ResolveMass Laboratories Inc.](/companies/resolvemass)
  - Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.
- [Sussex Research Laboratories Inc.](/companies/sussex-research)
  - Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.
